251 related articles for article (PubMed ID: 1965166)
1. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.
Chisolm JJ
Environ Health Perspect; 1990 Nov; 89():67-74. PubMed ID: 1965166
[TBL] [Abstract][Full Text] [Related]
2. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of edetate calcium disodium and dimercaptosuccinic acid in the treatment of lead poisoning in adults.
Sakthithasan K; Lévy P; Poupon J; Garnier R
Clin Toxicol (Phila); 2018 Nov; 56(11):1143-1149. PubMed ID: 29889577
[TBL] [Abstract][Full Text] [Related]
4. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
5. Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats.
Flora SJ; Bhattacharya R; Vijayaraghavan R
Fundam Appl Toxicol; 1995 May; 25(2):233-40. PubMed ID: 7665007
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of combined chelation in lead intoxication.
Tandon SK; Singh S; Jain VK
Chem Res Toxicol; 1994; 7(5):585-9. PubMed ID: 7841335
[TBL] [Abstract][Full Text] [Related]
7. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
8. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats.
Flora SJ; Tandon SK
Toxicology; 1990 Nov; 64(2):129-39. PubMed ID: 2171159
[TBL] [Abstract][Full Text] [Related]
10. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
[TBL] [Abstract][Full Text] [Related]
11. Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.
Meldrum JB; Ko KW
Am J Vet Res; 2003 Jun; 64(6):672-6. PubMed ID: 12828250
[TBL] [Abstract][Full Text] [Related]
12. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
[TBL] [Abstract][Full Text] [Related]
13. Reversing the adverse biochemical effects in lead-intoxicated rats by N,N`- bis[(1,2-didehydro-1-hydroxy-2-thioxopyrid-4-yl)-carbonyl]- L-lysine.
Ata SA; Abu-Dari KI; Tutunji MF; Mubarak MS
J Trace Elem Med Biol; 2018 Dec; 50():93-99. PubMed ID: 30262322
[TBL] [Abstract][Full Text] [Related]
14. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
16. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
Besunder JB; Super DM; Anderson RL
J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
[TBL] [Abstract][Full Text] [Related]
18. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
Glotzer DE
Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
Cory-Slechta DA
J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
[TBL] [Abstract][Full Text] [Related]
20. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
